Media library

First slide of the recording on the EMCDDA webinar on responding to stimulant use

EMCDDA webinar: Responding to stimulant use — developments in treatment

March 2023
Screenshot from the webinar on the past and present of methamphetamine

EMCDDA webinar: Methamphetamine in Europe — past and present

February 2023

EMCDDA: 30 years

janeiro 2023
map showing availability of drug testing in prisons in Europe

Overview of the use of drug testing programmes in prison settings in a number of European countries

janeiro 2023

Interventions to prevent opioid-related death by intended aim and evidence of benefit

janeiro 2023

Interventions used to target drug-related infectious diseases

janeiro 2023
Screenshot from the webinar on displaced populations and EU preparedness and responses

EMCDDA webinar: Displaced people and EU preparedness and response — lessons from Ukraine

December 2022
screenshot from video

EMCDDA webinar recording: How wastewater monitoring can boost preparedness for new health threats

December 2022
photo of Alexis Goosdeel, Director of the EMCDDA, and CEPOL Executive Director Montserrat Marín López

EMCDDA Director Alexis Goosdeel and CEPOL Executive Director Montserrat Marín López (Budapest, 28 November 2022)

November 2022
screenshot from video showing a map of the network

The Reitox network

November 2022
Location of Euro-DEN hospital centres in Europe

Location of Euro-DEN Plus centres — November 2022

November 2022
video cover — shows a doctor wearing blue gloves about to perform an autopsy

Drug-related deaths: why data matter to save lives

August 2022
Infographic showing opioids notifications and seizures

Infographic: opioids notifications to the Early Warning System and seizures

July 2022
Location of drug consumption facilities in Europe, November 2019. The map shows a concentration of facilities in Belgium, the Netherlands, Germany, Switzerland and parts of Spain

Infographic. Location and number of drug consumption facilities throughout Europe

July 2022
Infographic showing benzodiazepines notifications and seizures

Infographic: benzodiazepines notifications to the Early Warning System and seizures

July 2022
Infographic showing graphs on NPS notifications and seizures

Infographic: new psychoactive substances — notifications to the Early Warning System and seizures

July 2022
Cannabis users are the most likely to report using more than one drug other than their primary drug, followed by opioids and cocaine users.

Infographic: polydrug use among clients entering treatment by primary drug in the EU-27, Norway and Turkey, 2020

July 2022
Some key cannabis prevalance use data for young adults in Europe. Less than 20% have used cannabis in the last year. There are wide variations between countries, from 2% to over 20%. More men report using than women. Frequency of use varies widely.

Cannabis use in the last year in Europe – young adults (15-34)

July 2022
Infographic showing graphics and data on synthetic cathinones notifications and seizures

Infographic: synthetic cathinones notifications to the Early Warning System and seizures

July 2022
Graphics showing notifications and seizures of synthetic cannabinoids

Infographic: synthetic cannabinoids notifications to the Early Warning System and seizures

July 2022
Most clients entering treatment for cocaine in Europe are self-referred, in outpatient settings, in stable accomodation, male, with a range of employment statuses and use several times a week

Infographic: clients entering treatment for cocaine in Europe

July 2022
Infograhics shows overview of statistics of clients entering treatment for cannabis use in Europe. Most are men, in stable accomodation and self-referred. There are a range of employment statuses. Most are in stable accomodation.

Infographic: clients entering treatment for cannabis in Europe

July 2022
prevalence of last year amphetamines use among young people in Europe is low but there are wide geographical differences between countries, ranging from less than 1% to almost 5%

Infographic: amphetamines use in the last year in Europe – young adults (15-34)

July 2022
Futuristic image with the EMCDDA webinar title

EMCDDA webinar: Preparing for the future — applying a foresight approach in the drugs field

July 2022
Map showing estimates of prevalence of high risk opioid use in Europe. Rates range from below 1 to around 8 per 1000.

Last year prevalence of high-risk opioid use among adults in Europe

June 2022
While last year cocaine use among young people is low, in many countries in Europe it is close to 3%.

Infographic: cocaine use in the last year in Europe – young adults (15-34)

June 2022

EMCDDA webinar: Drug consumption rooms in Europe

June 2022
photo of Commissioner Ylva Johansson during her video speech for the launch of the 2022 European Drug Report

Launch of the 2022 European Drug Report: speech by Commissioner Ylva Johansson

June 2022
screen shot of Franz Pietsch before a European and Austrian flag making a speech

Launch of the 2022 European Drug Report: speech by Chair of EMCDDA Management Board Franz Pietsch

June 2022
Thumbnail from video — shows Alexis Goosdeel in front on an image of a smoke cloud with the words 'New challenges'

Recording of the online launch event of the European Drug Report 2022, 14 June 2022

June 2022
Loading